Teriparatide biosimilar (Teva)

特立帕肽生物类似药（Teva）

Report date: 2025/01/07 11:28:55

Base Information

Drug NameTeriparatide biosimilar (Teva)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionParathyroid hormone replacements

TargetsParathyroid hormone receptor

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsOsteoporosis

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIreland

Original Approved Date2018/06/22

Country/TerritoryIreland

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesTeva

China Registration ClassN/A

Develop Information

Active CompaniesTeva Bv

Inactive CompaniesN/A

Active IndicationsOsteoporosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A